Development of glycan-targeted nanoparticles as a novel therapeutic opportunity for gastric cancer treatment
Abstract Chemotherapy resistance remains a major cause of therapeutic failure in gastric cancer. The combination of genetic material such as interference RNAs (iRNAs) to silence cancer-associated genes with chemotherapeutics has become a novel approach for cancer treatment. However, finding the righ...
| Main Authors: | , , , , , , , , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
BMC
2023-03-01
|
| סדרה: | Cancer Nanotechnology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12645-023-00161-2 |